# Inmark, Inc. — Hazardous Materials Safety Interpretation

- **operation:** document
- **citation:** 09-0102
- **title:** Inmark, Inc. — Hazardous Materials Safety Interpretation
- **source type:** guidance
- **agency:** Pipeline and Hazardous Materials Safety Administration
- **status:** guidance
- **official:** true
- **published on:** 2009-05-05
- **effective on:** Not available
- **summary:** 09-0102 response to Inmark, Inc. concerning 173.196, 173.199.
- **machine formats:** - **json:** https://regulus.evalyn.ai/document/phmsa-interpretation-09-0102.json
- **markdown:** https://regulus.evalyn.ai/document/phmsa-interpretation-09-0102.md
- **app url:** https://regulus.evalyn.ai/document/phmsa-interpretation-09-0102
- **source url:** https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2009/090102.pdf
**body:**

<<<PAGE 1>>>

U.S. Department
of Transportation
Pipeline and Hazardous Materials
Safety Administration
1200 New Jersey Ave.. SE
Washington, DC 20590
Mr. Junius Johnson
Regulatory Compliance Manager
Inrnark, Inc.
675 Hartman Road, Suite 100
Austell, GA 30168
MAY 5 2009
Reference No. 09-01 02
Dear Mr. Johnson:
This is in response to your April 29, and April 30,2009 e-mails asking for clarification of the
classification and packaging requirements for the swine flu virus under the Hazardous
Materials Regulations (HMR; 49 CFR Parts 1 7 1 - 1 80). Specifically, you ask if the swine flu
virus must be classed as a Category A infectious substance during a pandemic. You also ask
if a specimen, regardless of whether or not it is infectious, must be classed as a Category A
infectious substance if it is collected fiom a region where a pandemic is occurring.
Based on information we received from the Centers for Disease Control and Prevention
(CDC) and the World Health Organization (WHO), it is our understanding that human and
animal specimen samples known or suspected of containing the swine flu virus or a Category
B infectious substance must be transported under the proper shipping description "UN 3373,
Biological substance, Category B, 6.2." Such samples must be transported in conformance
with the requirements prescribed in § 173.199 of the HMR. Cultures of the swine flu virus,
cultures of certain other Category B infectious substances, and Category A infectious
substances must be transported under the shipping description "UN 2814, Infectious
substances, affecting humans, 6.2," or "UN 2900, Infectious substances, affecting animals,
6.2," as appropriate. Swine flu cultures must be transported in conformance with the
requirements prescribed in 8 173.196.
Note that for purposes of the HMR a culture is defined as an infectious substance containing
a pathogen that has been intentionally propagated. The term does not include patient
specimens collected directly from humans or animals and transported for diagnosis, research,
or investigational purposes. Please see the definitions in 8 173.1 34.
I hope this satisfies your request. Please feel free to contact me if you have questions or
need additional information.
Sincerely,
Susan Gorsky d
Regulations Officer
Office of Hazardous Materials Standards

<<<PAGE 2>>>

Page 1 of 1
Drakeford, Carolyn CPHM
. -" .... . -" . .
From: Edmonson, Eileen <PHMSA>
Sent: Thursday, April 30, 2009 6:37 PM
To: Drakeford, Carolyn <PHIVISA>
Subject: Please give this letter a reference no. & assign it to me
From: Jay Johnson [mailto:jayj@inmarkinc.com]
Sent: Wednesday, April 29, 2009 5:15 PM
To: Gorsky, Susan <PHMSA>
Cc: Willke, Ted <PHMSA>; Frank Orvino
Subject: Classification of human biologic samples during a pandemic
Susan,
Thanks for your help in addressing this immediate concern to the transport of clinical samples during a pandemic.
We are getting calls from pharmaceutical companies and laboratories concerned about human samples coming
out of Central America (Mexico to be specific) as the Swine Flu worsens there. Sources are now saying that if a
pandemic is declared, then all biologics coming out of the area would be classified as Infectious Substance,
Category A (UN2814). I need something in writing to provide guidance to clinics and carriers on what is the
current classification for human body fluids with Swine Flu (currently they are classified as Biological Substance,
Category B (UN3373)) and if this classification changes when a pandemic is declared. More importantly, would
all biologic samples from a region (known infected or not known to be infected) change if a pandemic is declared
in a region?
Thanks for your help during this global outbreak,
Jay
Junius Johnson,
Regulatory Compliance Manager
lnmark Inc.
Austell, GA 30168
direct: 770.373.3356 i fax: 770.373.3357
. . ~ . i n m a r k i n c . c o m www.inmarkinc.com

<<<PAGE 3>>>

Page 1 of 1
Drakeford, Carolyn <PHMSA>
From: Edmonson, Eileen <PHMSA>
Sent: Thursday, April 30, 2009 6.37 PM
To : Drakeford, Carolyn cPHMSA>
Subject: Please give this letter a reference no. & assign it to me
From: Jay Johnson [mailto:jayj@inmarkinc.com]
Sent: Thursday, April 30, 2009 10:29 AM
To: Gorsky, Susan <PHMSA>
Cc: Willke, Ted <PHMSA>; Frank Orvino
Subject: RE: Classification of human biologic samples during a pandemic
Good Morning Susan,
Thanks for getting back to me so quickly with this. Having something in writing from you will go a long way in
securing that clinical trial samples continue to move in a timely manner during this crisis.
There are numerous clinical and safety samples that move from hospitals to labs every day which have nothing to
do with swine flu. However, the concern is that since they are coming from a region where the flu is present then
they may now be stopped or reclassified as a Category A and the patient's lives could be put in jeopardy from the
delay.
Thanks for your help,
Jay
Junius Johnson,
Regulatory Compliance Manager
lnmark Inc.
Austell, GA 30168
direct: 770.373.3356 1 fax: 770.373.3357
j.ayi@n.m.a_rk/l?_c.com w-,h_nma.rki.n.c..co.m
From: susan.gorsky@dot.gov [mailto:susan.gorsky@dot.gov]
Sent: Thursday, April 30, 2009 7:50 AM
To: Jay Johnson
Cc: Ted.Willke@dot.gov; Frank Orvino
Subject: RE: Classification of human biologic samples during a pandemic
Jay,
It is our understanding, based on information forwarded from IATA, that the World Health Organization is advising
health authorities to ship specimens taken from humans or animals that are suspected to contain the swine flu
virus under the shipping description "UN 3373, Biological Substance, Category B, 6.2." Such samples must be
transported in accordance with the requirements in 5 173.199 of the HMR. WHO advises health authorities to
ship cultures of the swine flu virus under the shipping description "UN 2814, Infectious substances affecting
humans, 6.2." Swine flu cultures must be transported in accordance with the requirements in 5 173.196. We plan
to confirm this information with CDC this morning and to ask if CDC expects this transportation advice to change if
a pandemic is declared. I will let you know what CDC tells us. Once we hear from CDC, I can put this information
in a formal letter if that would be helpful.
Susan
- **truncated:** false
- **body characters:** 6279
